1
|
Mutua F, Onono JO, Boqvist S, Koech P, Abdi AM, Karimi H, Sternberg-Lewerin S. Piloting an Information and Communication Technology Tool to Help Addressing the Challenge of Antimicrobial Resistance in Low-Income Countries. Antibiotics (Basel) 2025; 14:373. [PMID: 40298496 PMCID: PMC12024314 DOI: 10.3390/antibiotics14040373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2025] [Revised: 03/29/2025] [Accepted: 04/01/2025] [Indexed: 04/30/2025] Open
Abstract
Background/Objectives: Antimicrobial use (AMU) in livestock drives antimicrobial resistance (AMR). AMR has a significant impact on public health. While several interventions have been used to address this challenge, few have utilized Information and Communication Technology (ICT) approaches. The objective of this study was to pilot and assess an ICT system to monitor the use of veterinary drugs and disseminate information to farmers in peri-urban smallholder poultry systems in Kenya. Methods: The system was developed in collaboration with the stakeholders. It captures drug sales in veterinary pharmacies and disease incidence and treatments reported by farmers. The system was piloted from May 2023 to December 2023. Monthly follow-ups were conducted to monitor progress and address problems. Assessment was performed through focus group discussions with the users (two with farmers and two with veterinary pharmacy staff) and descriptive statistics of the data collected by the system. Results: A total of 15,725 records were obtained from veterinary pharmacies, including antibiotics (57%), dewormers (22%), and vitamins (11%). Requests for a specific product were recorded in 38% of the sales, while 63% were accompanied by some evidence (empty drug containers, old packages, old prescriptions, pictures of sick birds, and actual sick birds). A total of 91 records were obtained from the farmers. The health problems reported were mostly respiratory (40%) and digestive (30%) disorders. The percentage of customers who requested advice on animal health when visiting veterinary pharmacies ranged from 5 to 20%. Conclusions: AMU can be improved in the study area. The piloted system may help policymakers monitor the sales and usage of antibiotics, improve animal health management, and promote responsible AMU.
Collapse
Affiliation(s)
- Florence Mutua
- International Livestock Research Institute, Nairobi 00100, Kenya; (F.M.); (P.K.); (A.M.A.); (H.K.)
| | - Joshua Orungo Onono
- Department of Public Health, Pharmacology & Toxicology, University of Nairobi, Nairobi 00100, Kenya;
| | - Sofia Boqvist
- Department of Animal Biosciences, Swedish University of Agricultural Sciences, 75007 Uppsala, Sweden;
| | - Patricia Koech
- International Livestock Research Institute, Nairobi 00100, Kenya; (F.M.); (P.K.); (A.M.A.); (H.K.)
| | - Abdullahi M. Abdi
- International Livestock Research Institute, Nairobi 00100, Kenya; (F.M.); (P.K.); (A.M.A.); (H.K.)
| | - Hildah Karimi
- International Livestock Research Institute, Nairobi 00100, Kenya; (F.M.); (P.K.); (A.M.A.); (H.K.)
| | - Susanna Sternberg-Lewerin
- Department of Animal Biosciences, Swedish University of Agricultural Sciences, 75007 Uppsala, Sweden;
| |
Collapse
|
2
|
Eshete H, Tileku M, Aschenaki A, Shiferaw E, Mulugeta H, Teferi M, Shute T, Alemu A, Gerba H, Fentie AM. Ethiopian antimicrobial consumption trends in human health sector: A surveillance report 2020-2022. PLoS One 2025; 20:e0319295. [PMID: 40019905 PMCID: PMC11870371 DOI: 10.1371/journal.pone.0319295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2024] [Accepted: 01/30/2025] [Indexed: 03/03/2025] Open
Abstract
BACKGROUND Antimicrobial resistance (AMR) poses a severe global health threat, driven by the overuse and misuse of antimicrobials across the human, agricultural, and veterinary sectors. To combat this, global and national AMR prevention and containment strategies have been implemented, necessitating continuous monitoring of antimicrobial consumption (AMC) as an integral part of antimicrobial stewardship interventions. OBJECTIVE This study aims to assess and analyze trends in AMC in Ethiopia from 2020 to 2022, with the goal of informing national and sub-national strategies to combat AMR. METHODS A three-year AMC surveillance was conducted from 2020 to 2022. Data on locally manufactured and imported antimicrobials were collected from local manufacturers and Ethiopian Food and Drug Authority (EFDA)-regulated ports of entry. AMC was analyzed using the WHO GLASS AMC tool, with antimicrobials categorized using the WHO Anatomical Therapeutic Chemical (ATC) classification system. Consumption was measured in Defined Daily Doses (DDDs) and DDD per 1,000 inhabitants per day (DID), normalized using population estimates from the World Population Prospects for Ethiopia. RESULTS The total AMC in Ethiopia increased from 432 million DDDs in 2020 to 485 million DDDs in 2022. The DID rose from 10.63 in 2020 to 11.34 in 2022. Antibacterials dominated consumption, comprising 98.87% in 2020, 95.96% in 2021, and 99.79% in 2022. Penicillins (J01C) and quinolones (J01M) were the most consumed antimicrobials. As per the Ethiopian AWaRe classification, the majority of antibacterial agents consumed were in the Access group, accounting for 71.14% in 2020, 70.65% in 2021, and 74.2% in 2022. Oral formulations consistently made up over 87% of the total consumption each year. Reliance on imported antimicrobials remained high, with imports comprising 64.76% in 2020 and 74.47% in 2022. CONCLUSION The increasing trend in AMC in Ethiopia from 2020 to 2022 underscores the urgent need to establish and strengthen national, sub-national, and facility-level surveillance and reporting systems to better monitor and ensure rational antimicrobial use.
Collapse
Affiliation(s)
- Hailemariam Eshete
- Pharmacovigilance and Clinical trial lead executive office, Ethiopian Food and Drug Authority, Addis Ababa, Ethiopia
| | - Melaku Tileku
- School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
| | - Abiyot Aschenaki
- Pharmacovigilance and Clinical trial lead executive office, Ethiopian Food and Drug Authority, Addis Ababa, Ethiopia
| | - Eshetu Shiferaw
- Department of Pharmacy, Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia
| | - Haregewoin Mulugeta
- Pharmacovigilance and Clinical trial lead executive office, Ethiopian Food and Drug Authority, Addis Ababa, Ethiopia
| | - Mengistab Teferi
- Essential Drugs and Medicines, World Health Organization Ethiopia Country Office, Addis Ababa, Ethiopia
| | - Teshita Shute
- Pharmacovigilance and Clinical trial lead executive office, Ethiopian Food and Drug Authority, Addis Ababa, Ethiopia
| | - Asnakech Alemu
- Pharmacovigilance and Clinical trial lead executive office, Ethiopian Food and Drug Authority, Addis Ababa, Ethiopia
| | - Heran Gerba
- Ethiopian Food and Drug Authority, Addis Ababa, Ethiopia
| | - Atalay Mulu Fentie
- School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
| |
Collapse
|
3
|
Mudenda S, Lubanga AF, Jamshed S, Biemba B, Sakala R, Chiyabi M, Kavubya L, Milambo LT, Bumbangi FN, Chizimu JY, Yamba K, Wesangula E, Chigome A, Kalungia AC, Sefah IA, Mustafa ZUI, Massele AY, Saleem Z, Mutemwa R, Kazonga E, Sartelli M, Meyer JC, Muma JB, Chilengi R, Godman B. Point Prevalence Survey of Antibiotic Use in Level 1 hospitals in Zambia: Future Prospects for Antimicrobial Stewardship Programs. Infect Drug Resist 2025; 18:887-902. [PMID: 39975588 PMCID: PMC11837744 DOI: 10.2147/idr.s509522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2024] [Accepted: 02/07/2025] [Indexed: 02/21/2025] Open
Abstract
Introduction The inappropriate prescribing and use of antibiotics have contributed to the emergence and spread of antimicrobial resistance (AMR). In Zambia, there is a paucity of information on the prescribing patterns and use of antibiotics among hospitalized patients in level 1 hospitals. This study investigated antibiotic use in five level 1 hospitals in Lusaka, Zambia. Methods This cross-sectional study utilized the World Health Organization (WHO) Point Prevalence Survey (PPS) methodology among in-patients admitted in level 1 hospitals before 08:00 a.m. on the survey day in August 2024. Data were analysed using IBM SPSS version 23.0. Results The prevalence of antibiotic use among inpatients was 59.0%, with ceftriaxone being the most prescribed. Antibiotics were prescribed mainly for paediatrics and male inpatients. This study found that 53.0% of prescribed antibiotics were from the Access group while 38.2% were from the Watch group of the World Health Organization Access, Watch, and Reserve (AWaRe) classification. Adherence to national treatment guidelines was 36.0%, with most antibiotics prescribed empirically without evidence of culture and sensitivity tests. Conclusion This study found a high use of antibiotics and low adherence to treatment guidelines in level 1 hospitals in Lusaka, Zambia. The findings of this study demonstrate the need to establish and strengthen antimicrobial stewardship programs and strengthen laboratory capacity to aid clinicians in diagnosing, treating, and managing patients across level 1 hospitals in Zambia.
Collapse
Affiliation(s)
- Steward Mudenda
- Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka, Zambia
- Education and Continuous Professional Development Committee, Pharmaceutical Society of Zambia, Lusaka, Zambia
- Antimicrobial Resistance Coordinating Committee, Zambia National Public Health Institute, Lusaka, Zambia
| | - Adriano Focus Lubanga
- Education and Research, Clinical Research Education and Management Services (CREAMS), Lilongwe, Malawi
- Department of Clinical Services, Kamuzu Central Hospital (KCH), Lilongwe, Malawi
| | - Shazia Jamshed
- Department of Pharmacy Practice, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia
| | - Bibian Biemba
- Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka, Zambia
| | - Racheal Sakala
- Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka, Zambia
| | - Mervis Chiyabi
- Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka, Zambia
| | - Lorraine Kavubya
- Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka, Zambia
| | - Linda Twaambo Milambo
- Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka, Zambia
| | - Flavien Nsoni Bumbangi
- Department of Medicine and Clinical Sciences, School of Medicine, Eden University, Lusaka, Zambia
| | - Joseph Yamweka Chizimu
- Antimicrobial Resistance Coordinating Committee, Zambia National Public Health Institute, Lusaka, Zambia
| | - Kaunda Yamba
- Action on Antibiotic Resistance (React) Africa, Lusaka, Zambia
| | - Evelyn Wesangula
- Strengthening Pandemic Preparedness, Eastern, Central, and Southern Africa Health Community, Arusha, Tanzania
| | - Audrey Chigome
- Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Garankuwa, Pretoria, South Africa
| | | | - Israel Abebrese Sefah
- Pharmacy Practice Department, School of Pharmacy, University of Health and Allied Sciences, Volta Region, Ghana
| | - Zia U I Mustafa
- Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor, Penang, Malaysia
- Department of Pharmacy Services, District Headquarter (DHQ) Hospital, Pakpattan, 57400, Pakistan
| | - Amos Yared Massele
- Department of Clinical Pharmacology and Therapeutics, Kairuki University, Dar Es Salaam, Tanzania
| | - Zikria Saleem
- Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan
| | - Richard Mutemwa
- Department of Public Health, School of Medicine and Health Sciences, University of Lusaka, Lusaka, Zambia
| | - Eustarckio Kazonga
- Department of Public Health, School of Medicine and Health Sciences, University of Lusaka, Lusaka, Zambia
| | | | - Johanna Catharina Meyer
- Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Garankuwa, Pretoria, South Africa
- South African Vaccination and Immunisation Centre, Sefako Makgatho Health Sciences University, Garankuwa, Pretoria, South Africa
| | - John Bwalya Muma
- Department of Disease Control, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia
| | - Roma Chilengi
- Antimicrobial Resistance Coordinating Committee, Zambia National Public Health Institute, Lusaka, Zambia
| | - Brian Godman
- Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Garankuwa, Pretoria, South Africa
- Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
| |
Collapse
|
4
|
Kapatsa T, Lubanga AF, Bwanali AN, Harawa G, Mudenda S, Chipewa PC, Kamayani M, Makole TJ, Ali AY, Mohamed AA, Tae Youn K, Kim L, Daniel WD, Kim M, Chehab TE, Nyirenda T. Behavioral and Socio-Economic Determinants of Antimicrobial Resistance in Sub-Saharan Africa: A Systematic Review. Infect Drug Resist 2025; 18:855-873. [PMID: 39963371 PMCID: PMC11831910 DOI: 10.2147/idr.s503730] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2024] [Accepted: 02/04/2025] [Indexed: 02/20/2025] Open
Abstract
Introduction Antimicrobial resistance (AMR) is currently one of the twenty-first century's biggest threats to public health. Addressing AMR is often operationalized as requiring 'behavior change' of clinicians and patients and improving the drug development pipeline. Few studies and interventions have approached AMR as a challenge fundamentally embedded within the cultural fabric of modern societies and their varied economic, social and political organizations. This systematic review aimed to gather and review the available data on the behavioral and socio-economic determinants of AMR in sub-Saharan Africa (SSA). Methods Articles were sourced from PubMed using search terms across five domains: "Antimicrobial resistance", "Sub-Saharan Africa", "Behavioral", "Socio-economic", and specific SSA country names. References were also reviewed for relevant data. This systematic review included original studies published in English between 2015 and 2023, focusing on behavioral and socio-economic factors influencing AMR in human populations in SSA, with AMR as a key outcome. Results This systematic review identified 30 studies, with 83% (n=25) focusing on self-medication and antibiotic use practices, 67% (n=20) on healthcare providers' practices and knowledge, and 60% (n=18) on community knowledge and perceptions of AMR while 50% (n=15) of studies explored various socio-economic factors. The common themes that emerged from these studies included inadequate evidence-based prescription practices (63%, n=19), financial barriers to accessing antibiotics (50%, n=15), poor community awareness of AMR (53%, n=16), regulatory challenges in antibiotic sales and distribution (47%, n=14), and healthcare infrastructure limitations, including deficient diagnostic capabilities and antimicrobial stewardship programs (40%, n=12). Conclusion This review's findings provide crucial insights into the behavioral and socioeconomic patterns influencing AMR in sub-Saharan African populations. For AMR interventions to be effective, there is a need for a thorough understanding of people's behaviors and practices about AMR knowledge and antimicrobial use which will help in developing more targeted interventions and policies to address inappropriate antimicrobial use and the spread of AMR.
Collapse
Affiliation(s)
- Thandizo Kapatsa
- Education and Research, Clinical Research Education and Management Services (CREAMS), Lilongwe, Malawi
- Department of Laboratory Science, Dedza District Hospital, Ministry of Health, Dedza, Malawi
| | - Adriano Focus Lubanga
- Education and Research, Clinical Research Education and Management Services (CREAMS), Lilongwe, Malawi
- Department of Clinical Services, Kamuzu Central Hospital, Lilongwe, Malawi
| | - Akim N Bwanali
- Education and Research, Clinical Research Education and Management Services (CREAMS), Lilongwe, Malawi
- Department of Clinical Services, Queen Elizabeth Central Hospital, Blantyre, Malawi
| | - Gracian Harawa
- National Antimicrobial Resistance Coordinating Center, Public Health Institute of Malawi, Lilongwe, Malawi
- Society of Medical Doctors (SMD), Lilongwe, Malawi
| | - Steward Mudenda
- Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka, Zambia
| | - Pascal C Chipewa
- Malaria Alert Centre, Kamuzu University of Health Sciences, Blantyre, Malawi
| | | | | | | | - Abdullahi Abdirasak Mohamed
- School of Postgraduate Studies, Benazir University, Mogadishu, Somalia
- Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK
| | | | - Lorie Kim
- Youth With Talents, Fairfax, VA, USA
| | | | | | | | - Thomas Nyirenda
- European and Developing Countries Clinical Trials Partnership (EDCTP), Strategic Partnerships and Capacity Development, Cape Town, South Africa
- Department of Global Health, Stellenbosch University, Cape Town, South Africa
| |
Collapse
|
5
|
Abay GK, Shfare MT, Teklu TG, Kidane KM, Gebremeskel TK, Kahsay AG, Gezae KE, Muthupandian S, Degene TA. Extended-spectrum β-lactamase production and antimicrobial resistance among Enterobacteriaceae causing clinical infections in Africa: a systematic review and meta-analysis (2012-2020). Eur J Med Res 2025; 30:14. [PMID: 39773330 PMCID: PMC11706086 DOI: 10.1186/s40001-024-02267-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2024] [Accepted: 12/30/2024] [Indexed: 01/11/2025] Open
Abstract
BACKGROUND Worldwide, antimicrobial resistance (AMR) has grown to represent a serious threat to the diagnosis, management, and prevention of bacterial diseases. Due to their multidrug resistance attributes, the WHO has classified extended-spectrum-β-lactamase-producing Enterobacteriaceae (ESBL-PE)-associated infections as infections of critical significance, posing a serious risk to human health. Thus, the goal of this systematic review and meta-analysis was to assess the pooled prevalence of ESBL-PE and AMR among strains causing clinical infections in Africa. METHODS In this systematic review and meta-analysis, two investigators independently made an electronic search in Google Scholar and PubMed databases using related keywords and corresponding "MeSH." terms for the PubMed. The accessed studies were screened, assessed for eligibility, and critically evaluated as per the PRISMA guidelines. The prevalence and 95% confidence intervals (CI) for ESBL-PE in Africa were evaluated using a random-effects model of a meta-analysis. As a visual and statistical way assessment, the funnel plot and Egger's test were utilized to assess the risk of bias or publication bias, with a statistically significant level of bias being determined at p < 0.05. RESULTS Twenty-six studies were included in the meta-analysis. Among the included studies done in Africa, the overall pooled proportion of ESBL-PE was reported to be 28% (95% CI 25-31%). ESBL-PE prevalence differed by region, the pooled estimates for East and North Africa were 29% (95% CI 20-38%) and 19% (95% CI 6-33%), respectively. The greatest sub-group analysis of pooled estimates among bacterial isolates was found in Klebsiella. pneumoniae, at 73% (95% CI 62-85%), while Proteus mirabilis had the lowest, at 40% (95% CI 1-81%). CONCLUSIONS In Africa, ESBL-PE is noticeably prevalent. The included studies demonstrated a significant variation in ESBL-PE resistance among the countries. This illustrates the necessity of actively monitoring antimicrobial resistance in Africa to develop interventions aimed at halting the spread of ESBL-PE.
Collapse
Affiliation(s)
- Getahun Kahsay Abay
- Department of Medical Microbiology & Immunology, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia
| | - Mebrahtu Teweldemedhin Shfare
- Department of Medical Microbiology & Immunology, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia.
| | - Teklay Gebrecherkos Teklu
- Department of Medical Microbiology & Immunology, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia
| | - Kibriti Mehari Kidane
- Department of Medical Microbiology & Immunology, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia
- Tigray Health Research Institute, Mekelle, Tigray, Ethiopia
| | - Tsega Kahsay Gebremeskel
- Department of Medical Microbiology & Immunology, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia
- College of Health Sciences, Adigrat University, Adigrat, Tigray, Ethiopia
| | - Atsebaha Gebrekidan Kahsay
- Department of Medical Microbiology & Immunology, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia
| | - Kebede Embaye Gezae
- Department of Biostatistics, School of Public Health, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia
| | - Saravanan Muthupandian
- Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk 71491, Saudi Arabia
- Prince Fahad bin Sultan Chair for Biomedical Research, University of Tabuk, Tabuk 71491, Saudi Arabia
| | - Tsehaye Asmelash Degene
- Department of Medical Microbiology & Immunology, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia
| |
Collapse
|
6
|
Sorato MM. Health professional and facility engagement in antimicrobial resistance prevention and containment strategic initiatives at public hospitals in Southern Ethiopia: facility-based cross-sectional study. BMJ PUBLIC HEALTH 2025; 3:e002314. [PMID: 40260122 PMCID: PMC12010283 DOI: 10.1136/bmjph-2024-002314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/11/2024] [Accepted: 03/21/2025] [Indexed: 04/23/2025]
Abstract
Objective Antimicrobial resistance (AMR) threatens millions of lives and poses significant health, economic and development challenges. Policies implemented to prevent and contain AMR should address it through a One Health Approach. This study assessed health professional and facility engagement in Southern Ethiopia's AMR prevention and containment strategic initiatives and associated factors. Design A hospital-based cross-sectional study was conducted among 634 health professionals. Settings Five randomly selected public hospitals from three (Gofa, Gamo and South Omo) zones. Participants Health professionals working in the outpatient department in the randomly selected hospitals. Outcome measure Health professional and facility engagement in AMR prevention and containment strategies. A binary logistic regression model was used to evaluate the association between the explanatory variables (socio-demographic characteristics, institutional and professional factors) and dependent variables (professional engagement in AMR PCSIs). To avoid many variables and unstable estimates and control possible confounders in the subsequent model, only variables that reached a p value less than 0.25 at binary analysis were used in the multivariate logistic regression analysis to identify factors independently associated with health professional and facility engagement level in AMR prevention and containment strategies. Result This study included 634 participants (56.5% males). Among these professionals, the vast majority (n=444, 70.0%) were aware of the One Health perspective on AMR. Concerning health facility engagement in AMR PCSIs, about one-third (n=203; 32.0%) of professionals reported full engagement in the facilities. Nearly one-fourth of professionals (n=169; 26.7%) reported including AMR prevention and containment procedures in their facility's annual plan. The overall health professional and facility engagement in AMR PCSIs was 412 (65.0%). Having a history of sharp injury (adjusted odds ratio (AOR)=1.88 (1.19, 2.97; p=0.007)), working in a general hospital (AOR=3.746 (2.657, 5.282; p=0.000)), having good knowledge on healthcare waste management (AOR=1.99 (1.225, 3.258; p=0.006)) and being from a facility that included AMR prevention and containment in the annual plan (AOR=3.796 (2.01, 7.180; p=0.000)) were positively and independently associated with the dependent variable (professional engagement in AMR PCSIs). However, a working experience of 6-10 years (AOR=0.6 (0.32, 0.96, p<0.05)), receiving infection prevention control training (AOR=1.47 (1.02, 2.13, p=0.041)) and lack of adequate knowledge on One Health approach (AOR=0.50 (0.32, 0.79; p=0.003)) were negatively associated with professional and facility engagement in AMR PCSIs. Conclusion In the study area, professional and facility engagement in AMR PCSIs was low. Providing training on infection prevention and control, healthcare waste handling, One Health approach, antimicrobial stewardship for all and disseminating national strategic initiatives to all levels in the healthcare system are important. Researchers willing to work in similar areas must use mixed-method study designs to evaluate the engagement of all (human, animal and environmental) stakeholders toward AMR PCSIs.
Collapse
Affiliation(s)
- Mende Mensa Sorato
- Department of Pharmacy, School of Medicine, Komar University of Science and Technology, Sulaymania, Iraq
- Department of Pharmacy, College of Medicine and Health Science, Arba Minch University, Arba Minch, Ethiopia
| |
Collapse
|
7
|
Mafe AN, Büsselberg D. Impact of Metabolites from Foodborne Pathogens on Cancer. Foods 2024; 13:3886. [PMID: 39682958 DOI: 10.3390/foods13233886] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2024] [Revised: 11/28/2024] [Accepted: 11/29/2024] [Indexed: 12/18/2024] Open
Abstract
Foodborne pathogens are microorganisms that cause illness through contamination, presenting significant risks to public health and food safety. This review explores the metabolites produced by these pathogens, including toxins and secondary metabolites, and their implications for human health, particularly concerning cancer risk. We examine various pathogens such as Salmonella sp., Campylobacter sp., Escherichia coli, and Listeria monocytogenes, detailing the specific metabolites of concern and their carcinogenic mechanisms. This study discusses analytical techniques for detecting these metabolites, such as chromatography, spectrometry, and immunoassays, along with the challenges associated with their detection. This study covers effective control strategies, including food processing techniques, sanitation practices, regulatory measures, and emerging technologies in pathogen control. This manuscript considers the broader public health implications of pathogen metabolites, highlighting the importance of robust health policies, public awareness, and education. This review identifies research gaps and innovative approaches, recommending advancements in detection methods, preventive strategies, and policy improvements to better manage the risks associated with foodborne pathogens and their metabolites.
Collapse
Affiliation(s)
- Alice N Mafe
- Department of Biological Sciences, Faculty of Sciences, Taraba State University, Main Campus, Jalingo 660101, Taraba State, Nigeria
| | - Dietrich Büsselberg
- Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha Metropolitan Area P.O. Box 22104, Qatar
| |
Collapse
|
8
|
Tlhapi D, Malebo N, Manduna IT, Lautenschläger T, Mawunu M. A Review of Medicinal Plants Used in the Management of Microbial Infections in Angola. PLANTS (BASEL, SWITZERLAND) 2024; 13:2991. [PMID: 39519911 PMCID: PMC11548206 DOI: 10.3390/plants13212991] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/17/2024] [Revised: 10/21/2024] [Accepted: 10/24/2024] [Indexed: 11/16/2024]
Abstract
The use of medicinal plants in the management of microbial infections is significant to the health of the indigenous people in many Angolan communities. The present study provides a comprehensive overview of medicinal plants used for the management of microbial infections in Angola. Relevant information was extracted from research articles published and associated with the use of medicinal plants in the management of microbial infections in Angola (from January 1976 to November 2023). Data or information were gathered from the literature sourced from Wiley Online, SciFinder, Google Scholar, Web of Science, Scopus, ScienceDirect, BMC, Elsevier, SpringerLink, PubMed, books, journals and published M.Sc. and Ph.D. thesis. A total of 27 plant species, representing 19 families, were recorded in this study. Hypericaceae (11%), Lamiaceae (11%), Malvaceae (11%), Phyllanthaceae (11%), Fabaceae (16%) and Rubiaceae (16%) were the most predominant families. The leaves are the most used parts (96%), followed by bark (74%) and root (70%). The data revealed that medicinal plants continue to play significant roles in the management of microbial infections in Angola. In order to explore the benefits of the therapeutic potential of indigenous medicinal plants for diseases related to infections; further scientific research studies are important to produce data on their effectiveness using appropriate test models. This approach might assist with the continuing drive regarding the integration of Angolan traditional medicine within mainstream healthcare systems.
Collapse
Affiliation(s)
- Dorcas Tlhapi
- Centre for Applied Food Sustainability and Biotechnology, Faculty of Health and Environmental Sciences, Central University of Technology, Bloemfontein 9300, South Africa;
| | - Ntsoaki Malebo
- Centre for Innovation in Learning and Teaching, Central University of Technology, Bloemfontein 9300, South Africa;
| | - Idah Tichaidza Manduna
- Centre for Applied Food Sustainability and Biotechnology, Faculty of Health and Environmental Sciences, Central University of Technology, Bloemfontein 9300, South Africa;
| | | | - Monizi Mawunu
- Department of Agronomy, Polytechnic Institute, Kimpa Vita University, Luanda P.O. Box 77, Angola;
| |
Collapse
|
9
|
Merga KH, Getachew EM, Fujita AW, Abayneh M, Jacob JT, Ali S, Melesse HO, Babiker A, Getachew LS, Hailu T, Mohammed J, Solomon B, Rebolledo PA, Abdissa A, Kempker RR. A high prevalence of antibiotic use at two large teaching hospitals in Addis Ababa, Ethiopia: a point prevalence survey. ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY : ASHE 2024; 4:e180. [PMID: 39450096 PMCID: PMC11500273 DOI: 10.1017/ash.2024.432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/31/2024] [Revised: 08/20/2024] [Accepted: 08/21/2024] [Indexed: 10/26/2024]
Abstract
Objective Antimicrobial resistance (AMR) renders many bacterial infections untreatable and results in substantial morbidity and mortality worldwide. Understanding antibiotic use in clinical settings including hospitals is critical to optimize antibiotic use and prevent resistance. Design Hospital antibiotic point prevalence survey (PPS). Methods The study was conducted in two large, teaching hospitals in Addis Ababa, Ethiopia. We performed two survey rounds in December 2021 and January 2022 through real-time chart review using the World Health Organization PPS methodology. Data were collected using a web-based database, and descriptive statistics were performed to analyze antibiotic use by various characteristics. Results Among 1020 hospitalized patients, 318 (32%) were ≤14 years and 370 (36%) had surgery during the current hospitalization. A total of 662 (65%) were receiving an antibiotic on the day of survey and 346 (39%) were receiving ≥2 antibiotics. A community-acquired infection (43%) was the most common indication for an antibiotic followed by surgical prophylaxis (27%) and hospital-acquired infection (23%). Antibiotic use was highest among those ≤24 months in age and among patients in trauma, surgical, and pediatric wards. Cephalosporin (42%) and penicillin (16%) antibiotics were the most frequently prescribed classes. Only 11% of patients on antibiotics had samples collected for microbiological testing; hence, almost all antibiotic therapy was empiric. Conclusions Despite global and national efforts to improve antimicrobial stewardship, antibiotic use remains high in urban teaching hospitals in Ethiopia. Implementation of antimicrobial stewardship activities and microbiology utilization are needed to guide antimicrobial selection and curtail antibiotic overuse.
Collapse
Affiliation(s)
| | | | - Ayako Wendy Fujita
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, USA
| | - Mahlet Abayneh
- St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia
| | - Jesse T. Jacob
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, USA
| | - Solomon Ali
- St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia
| | | | - Ahmed Babiker
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, USA
| | | | - Tsegaye Hailu
- Armauer Hansen Research Institute, Addis Ababa, Ethiopia
| | - Jemal Mohammed
- Armauer Hansen Research Institute, Addis Ababa, Ethiopia
| | | | - Paulina A. Rebolledo
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, USA
| | | | - Russell R. Kempker
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, USA
| |
Collapse
|
10
|
Isse SA, Doğan A, Ali TA, Wehlie JA, Adam AA, Öztürk H. Hand Hygiene Compliance and Its Associated Factors Among Health Care Workers at Mogadishu Somali Turkiye Recep Tayyip Erdoğan Training and Research in a Tertiary Care Hospital. Risk Manag Healthc Policy 2024; 17:2415-2425. [PMID: 39429694 PMCID: PMC11490245 DOI: 10.2147/rmhp.s481057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2024] [Accepted: 10/04/2024] [Indexed: 10/22/2024] Open
Abstract
Background Hand hygiene is a critical preventive measure for controlling infections, particularly in underdeveloped nations. Materials and Methods A cross-sectional study was conducted in a hospital in Mogadishu, Somalia, from January to March 2024. This study aimed to assess compliance with hand hygiene practices and related factors among healthcare professionals. Results The study population comprised 52% men and 47.3% women. Most participants held bachelor's degrees, with the majority being nurses or midwives. A significant proportion had over five years of work experience. Almost all participants were knowledgeable about hand hygiene. Most reported cleaning and drying their hands before, during, and after contact with bodily fluids during aseptic procedures. Age, gender, educational status, marriage, working experience, type of occupation, receiving hand hygiene training and knowledge, and having the availability of water, soap, alcohol, and gloves significantly affected the overall uptake of infection control measures in Mogadishu (p<0.05). Conclusion The findings highlight an urgent need for targeted interventions to enhance hand hygiene practices in Somalia. Addressing training gaps and resource shortages is crucial for reducing infection rates and safeguarding patient health in this high-risk setting.
Collapse
Affiliation(s)
- Suad Abdikarim Isse
- Department of Infectıon Preventıon Control, Mogadıshu Somalı Turkıye Recep Tayyıp Erdogan Traınıng and Research Hospıtal, Mogadishu, Somalia
| | - Ahmet Doğan
- Department of Infectious Diseases and Clinical Microbiology, Abant Izzet Baysal University Faculty of Medicine, Bolu, Turkiye
| | - Tigad Abdisad Ali
- Department of Infectıon Preventıon Control, Mogadıshu Somalı Turkıye Recep Tayyıp Erdogan Traınıng and Research Hospıtal, Mogadishu, Somalia
| | | | - Abdirahim Ali Adam
- Department of Infectious Diseases and Clinical Microbiology, Mogadishu-Somalia-Turkiye Recep Tayyip Erdoğan Training and Research Hospital, Mogadishu, Somalia
| | - Hüsna Öztürk
- Department of Infectious Control Nurse Istanbul Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi, Istanbul, Turkiye
| |
Collapse
|
11
|
Alhassan JAK, Abdallah CK. Health system interventions and responses to anti-microbial resistance: A scoping review of evidence from 15 African countries. PLOS GLOBAL PUBLIC HEALTH 2024; 4:e0003688. [PMID: 39292696 PMCID: PMC11410274 DOI: 10.1371/journal.pgph.0003688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/12/2023] [Accepted: 08/13/2024] [Indexed: 09/20/2024]
Abstract
The global rise in antimicrobial resistance (AMR) is claiming the lives of more than 1.2 million people each year. According to the World Health Organization (WHO) this global health crisis is particularly acute in Africa, largely due to fragile and underfunded health systems. Efforts to combat this public health threat have led to the implementation of health system interventions worldwide aimed at managing and containing the spread of AMR. However, the literature on the real time impacts and the barriers that hinder the implementation of these interventions in the African context is limited. The objective of this scoping review was to identify AMR interventions in African health systems, their impact, and the challenges of the implementation. Drawing on Muka and colleague's 24 step approach for scoping reviews, two major public health databases (PubMed and Global Health) were searched for articles in accordance with the PRISMA guidelines resulting in 4,783 records. Screening and retrieval of articles was done using Rayyan software based on specified inclusion criteria and 36 articles included in the final list. These articles were synthesized after extracting specific data on AMR interventions and their impact on African health systems. The review identified four broad impacts of AMR interventions including 1. Reduction in antibiotics use, 2. Increased adherence to guidelines and protocols, 3. Enhanced laboratory-based AMR surveillance, 4. Development of antimicrobial stewardship (AMS) Action Plans and Teams. However, challenges such as poor laboratory infrastructure, logistical challenges, poor financial commitment and inadequate education and training were identified as challenges impeding the successful implementation of AMR interventions in Africa. Our findings reveal a range of successful AMR interventions in African health systems although infrastructural and financial challenges remain. Better standardization and reporting of AMR diagnosis while leveraging the available information is needed to improve the optimization of treatment guidelines across Africa.
Collapse
Affiliation(s)
- Jacob Albin Korem Alhassan
- Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, Saskatoon, Canada
- Ad Astra Foundation, Tamale, Ghana
| | - Clement Kamil Abdallah
- Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, Saskatoon, Canada
- Ad Astra Foundation, Tamale, Ghana
| |
Collapse
|
12
|
Bennett C, Russel W, Upton R, Frey F, Taye B. Social and ecological determinants of antimicrobial resistance in Africa: a systematic review of epidemiological evidence. ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY : ASHE 2024; 4:e119. [PMID: 39257424 PMCID: PMC11384158 DOI: 10.1017/ash.2024.375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/20/2024] [Revised: 05/20/2024] [Accepted: 05/22/2024] [Indexed: 09/12/2024]
Abstract
Background Antimicrobial resistance (AMR) is one of the greatest global health problems for humans, animals, and the environment. Although the association between various factors and AMR is being increasingly researched, the need to understand the contribution of social and ecological determinants, especially in developing nations, remains. This review fills these knowledge gaps by synthesizing existing evidence on the social and ecological determinants of AMR in Africa. Results Twenty-four studies were selected based on predefined criteria from PubMed. 58.33% (n = 14) and 29.17% (n = 7) of the studies reported on ecological and social determinants of AMR, respectively, and 3 (12.5%) studies documented both social and environmental determinants of AMR. Sociodemographic factors include increased household size, poor knowledge, attitudes toward AMR, low educational levels, and rural residences. Indicators of poor water sanitation and hygiene, framing practices, and consumption of farm products were among the common ecological determinants of AMR and AM misuse in Africa. Conclusion Our review demonstrates the importance of social and ecological determinants of AMR among African populations. The findings may be valuable to researchers, policymakers, clinicians, and those working in lower-income countries to implement AMR prevention programs utilizing a holistic approach.
Collapse
Affiliation(s)
- Catherine Bennett
- Department of Neuroscience, Colgate University, Hamilton, NY, USA
- Global Public Environmental Health, Colgate University, Hamilton, NY, USA
| | - Will Russel
- Global Public Environmental Health, Colgate University, Hamilton, NY, USA
- Department of Biology, Colgate University, Hamilton, NY, USA
| | - Rebecca Upton
- Global Public Environmental Health, Colgate University, Hamilton, NY, USA
| | - Frank Frey
- Global Public Environmental Health, Colgate University, Hamilton, NY, USA
- Department of Biology, Colgate University, Hamilton, NY, USA
| | - Bineyam Taye
- Global Public Environmental Health, Colgate University, Hamilton, NY, USA
- Department of Biology, Colgate University, Hamilton, NY, USA
| |
Collapse
|
13
|
Tsakem B, Li G, Teponno RB. Structures, biosynthesis and biological activities of benastatins, anthrabenzoxocinones and fredericamycins. Bioorg Chem 2024; 150:107572. [PMID: 38901281 DOI: 10.1016/j.bioorg.2024.107572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2024] [Revised: 06/16/2024] [Accepted: 06/17/2024] [Indexed: 06/22/2024]
Abstract
The fast spread of antibiotic resistance results in the requirement for a constant introduction of new candidates. Pentangular polyphenols, a growing family of actinomycetes-derived aromatic type II polyketides, have attracted considerable attention due to their intriguing polycyclic systems and potent antimicrobial activity. Among them, benastatins, anthrabenzoxocinones (ABXs), and fredericamycins, display unique variations in their polycyclic frameworks, yet concurrently share structural commonalities within their substitutions. The present review summarizes advances in the isolation, spectroscopic characteristics, biosynthesis, and biological activities of pentangular polyphenols benastatins (1-16), ABXs (17-39), and fredericamycins (40-42) from actinomycetes. The information presented here thus prompts researchers to further explore and discover additional congeners within these three small classes of pentangular polyphenols.
Collapse
Affiliation(s)
- Bienvenu Tsakem
- Department of Chemistry, Faculty of Science, University of Dschang, P.O. Box 67, Dschang, Cameroon
| | - Gang Li
- China-Cameroon Joint Laboratory on Bioactive Natural Products from Endophytes, Department of Natural Medicinal Chemistry and Pharmacognosy, School of Pharmacy, Qingdao University, Qingdao 266071, People's Republic of China.
| | - Rémy Bertrand Teponno
- Department of Chemistry, Faculty of Science, University of Dschang, P.O. Box 67, Dschang, Cameroon.
| |
Collapse
|
14
|
Boltena MT, Wolde M, Hailu B, El-Khatib Z, Steck V, Woldegerima S, Siraneh Y, Morankar S. Point prevalence of evidence-based antimicrobial use among hospitalized patients in sub-Saharan Africa: a systematic review and meta-analysis. Sci Rep 2024; 14:12652. [PMID: 38825623 PMCID: PMC11144712 DOI: 10.1038/s41598-024-62651-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2024] [Accepted: 05/20/2024] [Indexed: 06/04/2024] Open
Abstract
Excessive and improper use of antibiotics causes antimicrobial resistance which is a major threat to global health security. Hospitals in sub-Saharan Africa (SSA) has the highest prevalence of antibiotic use. This systematic review and meta-analysis aimed to determine the pooled point prevalence (PPP) of evidence-based antimicrobial use among hospitalized patients in SSA. Literature was retrieved from CINAHL, EMBASE, Google Scholar, PubMed, Scopus, and Web of Science databases. Meta-analysis was conducted using STATA version 17. Forest plots using the random-effect model were used to present the findings. The heterogeneity and publication bias were assessed using the I2 statistics and Egger's test. The protocol was registered in PROSPERO with code CRD42023404075. The review was conducted according to PRISMA guidelines. A total of 26, 272 study participants reported by twenty-eight studies published from 10 countries in SSA were included. The pooled point prevalence of antimicrobial use in SSA were 64%. The pooled estimate of hospital wards with the highest antibiotic use were intensive care unit (89%). The pooled prevalence of the most common clinical indication for antibiotic use were community acquired infection (41%). The pooled point prevalence of antimicrobial use among hospitalized patients were higher in SSA. Higher use of antibiotics was recorded in intensive care units. Community acquired infection were most common clinical case among hospitalized patients. Health systems in SSA must design innovative digital health interventions to optimize clinicians adhere to evidence-based prescribing guidelines and improve antimicrobial stewardship.
Collapse
Affiliation(s)
- Minyahil Tadesse Boltena
- Ethiopian Evidence Based Health Care Centre: A Joanna Briggs Institute's Center of Excellence, Faculty of Public Health, Institute of Health, Jimma University, Jimma, Ethiopia.
- Armauer Hansen Research Institute, Ministry of Health, Addis Ababa, Ethiopia.
| | - Mirkuzie Wolde
- Ethiopian Evidence Based Health Care Centre: A Joanna Briggs Institute's Center of Excellence, Faculty of Public Health, Institute of Health, Jimma University, Jimma, Ethiopia
- University of Technology Sydney, Sydney, Australia
| | - Belachew Hailu
- Armauer Hansen Research Institute, Ministry of Health, Addis Ababa, Ethiopia
| | - Ziad El-Khatib
- Global Public Health Department, Karolinska Institute, Solna, Sweden
| | - Veronika Steck
- Department of Pharmacology and Therapeutics, Faculty of Life Sciences, McGill University, Montreal, Canada
| | - Selam Woldegerima
- Nuffield Department of Population Health, University of Oxford, Oxford, UK
| | - Yibeltal Siraneh
- Ethiopian Evidence Based Health Care Centre: A Joanna Briggs Institute's Center of Excellence, Faculty of Public Health, Institute of Health, Jimma University, Jimma, Ethiopia
| | - Sudhakar Morankar
- Ethiopian Evidence Based Health Care Centre: A Joanna Briggs Institute's Center of Excellence, Faculty of Public Health, Institute of Health, Jimma University, Jimma, Ethiopia
| |
Collapse
|
15
|
Lubanga AF, Bwanali AN, Kambiri F, Harawa G, Mudenda S, Mpinganjira SL, Singano N, Makole T, Kapatsa T, Kamayani M, Ssebibubbu S. Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines. Expert Rev Anti Infect Ther 2024; 22:379-386. [PMID: 38809689 DOI: 10.1080/14787210.2024.2362270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2024] [Accepted: 05/28/2024] [Indexed: 05/31/2024]
Abstract
INTRODUCTION Antimicrobial drugs form an essential component of medical treatment in human and animal health. Resistance associated with their use has posed a global public health threat. Multiple efforts have been made at the global level directed by the World Health Organization and associated partners to develop policies aimed at combatting antimicrobial resistance. AREAS COVERED Whilst the Global Action Plan on antimicrobial resistance and people-centered framework aim to guide countries in implementing successful antimicrobial resistance policies, their adoption and success depend on different implementation contexts. Therefore, this paper highlights the challenges and opportunities for implementing the World Health Organization's people-centered approach in sub-Saharan Africa, whilst recognizing antimicrobial resistance as a multifaceted problem rooted in 'complex systems.' EXPERT OPINION The people-centered approach provides a solid framework for combating antimicrobial resistance. Countries should build sustainable national action plans, adopt the One Health approach, limit over-the-counter antibiotic consumption, and educate communities on rational antibiotic use. They should also promote inter-country collaborations and innovative solutions, strengthen drug regulatory capacities, invest in infection control, water sanitation, hygiene, diagnostics, and surveillance tools, and promote vaccine uptake to prevent drug-resistant infections.
Collapse
Affiliation(s)
- Adriano Focus Lubanga
- Education and Research, Clinical Research Education and Management Services (CREAMS), Lilongwe, Malawi
- Department of Clinical Services, Kamuzu Central Hospital (KCH), Lilongwe, Malawi
| | - Akim Nelson Bwanali
- Education and Research, Clinical Research Education and Management Services (CREAMS), Lilongwe, Malawi
- Department of Clinical Services, Queen Elizabeth Central Hospital (QECH), Blantyre, Malawi
| | - Frank Kambiri
- Education and Research, Clinical Research Education and Management Services (CREAMS), Lilongwe, Malawi
| | - Gracian Harawa
- Antimicrobial Resistance Champion, Public Health Institute of Malawi (PHIM), Lilongwe, Malawi
| | - Steward Mudenda
- Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka, Zambia
| | - Samuel L Mpinganjira
- Department of Epidemiology and Statistics, Kamuzu University of Health Sciences, Blantyre, Malawi
| | - Nathan Singano
- Department of Disease Control, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia
| | - Tumaini Makole
- Pharmacist, Pharmacy Council of Tanzania, Dar es Salaam, Tanzania
| | - Thandizo Kapatsa
- Department of Laboratory Science, Phalombe District Hospital, Ministry of Health, Phalombe, Malawi
| | - Mapeesho Kamayani
- Disease Surveillance, Churches Association of Zambia, Lusaka, Zambia
| | - Stuart Ssebibubbu
- Afya na Haki Institute, Department of Evidence Generated, Kampala, Uganda
| |
Collapse
|
16
|
Isah MB, Yusuf A, Usman A, Dang M, Zhang X. Mapping the landscape of IgY antibody research in Africa: A capacity and output analysis. SCIENTIFIC AFRICAN 2024; 23:e02019. [DOI: 10.1016/j.sciaf.2023.e02019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2025] Open
|
17
|
Mudenda S, Chilimboyi R, Matafwali SK, Daka V, Mfune RL, Kemgne LAM, Bumbangi FN, Hangoma J, Chabalenge B, Mweetwa L, Godman B. Hospital prescribing patterns of antibiotics in Zambia using the WHO prescribing indicators post-COVID-19 pandemic: findings and implications. JAC Antimicrob Resist 2024; 6:dlae023. [PMID: 38389802 PMCID: PMC10883698 DOI: 10.1093/jacamr/dlae023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2023] [Accepted: 02/02/2024] [Indexed: 02/24/2024] Open
Abstract
Background Antimicrobial resistance (AMR) is a global public health problem that is fuelled by the inappropriate prescribing of antibiotics, especially those from the 'watch' and 'reserve' antibiotic lists. The irrational prescribing of antibiotics is particularly prevalent in developing countries, including Zambia. Consequently, there is a need to better understand prescribing patterns across sectors in Zambia as a basis for future interventions. This study evaluated the prescribing patterns of antibiotics using the WHO prescribing indicators alongside the 'access, watch and reserve' (AWaRe) classification system post-COVID pandemic at a faith-based hospital in Zambia. Methods A cross-sectional study was conducted from August 2023 to October 2023 involving the review of medical records at St. Francis' Mission Hospital in Zambia. A WHO-validated tool was used to evaluate antibiotic prescribing patterns alongside the AWaRe classification tool. Results Out of 800 medical records reviewed, 2003 medicines were prescribed. Each patient received an average of 2.5 medicines per prescription. Antibiotics were prescribed in 72.3% of encounters, of which 28.4% were injectable. The most frequently prescribed antibiotics were amoxicillin (23.4%-access), metronidazole (17.1%-access), ciprofloxacin (8%-watch) and ceftriaxone (7.4%-watch), with 77.1% overall from the 'access' list. Encouragingly, 96.5% of the medicines were prescribed by their generic names and 98% were from the Zambia Essential Medicines List. Conclusions There were high rates of antibiotic prescribing, including injectable antibiotics, which needs addressing going forward. It is crucial to implement targeted measures, including antimicrobial stewardship programmes, to improve future antibiotic prescribing in Zambia and reduce the risk of AMR.
Collapse
Affiliation(s)
- Steward Mudenda
- Department of Pharmacy, School of Health Sciences, University of Zambia, P.O. Box 50110, Lusaka, Zambia
| | - Robert Chilimboyi
- Department of Pharmacy, School of Health Sciences, University of Zambia, P.O. Box 50110, Lusaka, Zambia
- Department of Pharmacy, Saint Francis' Hospital, Private Bag 11, Katete, Zambia
| | - Scott Kaba Matafwali
- Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK
| | - Victor Daka
- Department of Public Health, Michael Chilufya Sata School of Medicine, Copperbelt University, P.O. Box 71191, Ndola, Zambia
| | - Ruth Lindizyani Mfune
- Department of Public Health, Michael Chilufya Sata School of Medicine, Copperbelt University, P.O. Box 71191, Ndola, Zambia
| | | | - Flavien Nsoni Bumbangi
- Department of Medicine and Clinical Sciences, School of Medicine, Eden University, P.O. Box 30226, Lusaka, Zambia
| | - Jimmy Hangoma
- Department of Pharmacy, School of Health Sciences, Levy Mwanawasa Medical University, Lusaka, Zambia
| | - Billy Chabalenge
- Department of Medicines Control, Zambia Medicines Regulatory Authority, P.O. Box 31890, Lusaka, Zambia
| | - Larry Mweetwa
- Department of Science and Technology, Ministry of Technology and Science, Maxwell House, Los Angeles Boulevard, P. O. Box 50464, Lusaka, Zambia
| | - Brian Godman
- Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa 0208, South Africa
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK
| |
Collapse
|
18
|
Jere E, Munkombwe D, Mukosha M, Mudenda S, Kalungia AC, Chabalenge B. Quality of antiretroviral, antimalarial and antituberculosis medicines in Zambia: Findings of routine post-marketing surveillance. THE JOURNAL OF MEDICINE ACCESS 2024; 8:27550834241266755. [PMID: 39071988 PMCID: PMC11273717 DOI: 10.1177/27550834241266755] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/03/2023] [Accepted: 06/14/2024] [Indexed: 07/30/2024]
Abstract
Background There is growing concern in sub-Saharan Africa that poor-quality antimicrobial medicines may negate management of infectious diseases of public health importance should they fail to meet the set criteria of quality, safety and efficacy. Objectives The objective was to ascertain the quality of antiretroviral, antimalarial and antituberculosis medicines supplied and available in the public health sector in Zambia. Design A descriptive cross-sectional study was conducted involving the analysis of data from the continuous routine in-country post-marketing surveillance programme in Zambia that assessed the quality of antiretroviral, antimalarial and antituberculosis medicines supplied to public healthcare facilities between January 2018 and June 2023. Methods Data were extracted from laboratory quality analysis results from samples collected as part of routine post-marketing surveillance by the Zambia Medicines Regulatory Authority between January 2018 and June 2023. The samples were collected from various levels of the pharmaceutical supply chain across Zambia. Samples were analysed according to their respective pharmacopoeia standards at the Medicines Control Authority of Zimbabwe Quality Control Laboratory, a World Health Organization prequalified laboratory. Data were extracted using a structured Excel database and analysed using Microsoft Excel, and GraphPad Prism Software was used for visualizations. Results Of the 198 samples, 86 (43.43%) were antiretrovirals, 54 (27.27%) antimalarials and 58 (29.29%) antituberculosis medicines. Of these 198 samples, 171 (86.36%) originated from Asia, 19 (9.60%) Africa and 8 (4.04%) Europe. All sampled medicines met their respective quality specifications with respect to tests, which included appearance, identification, assay, uniformity of mass, weight variation, disintegration, dissolution, pH and specific gravity, giving a compliance rate of 100%. Conclusion Antiretrovirals, antimalarials and antituberculosis medicines obtained from public healthcare facilities in Zambia through routine post-marketing surveillance met their quality standards. This might positively impact treatment outcomes for HIV/AIDS, malaria and tuberculosis. There is a need for large-scale continuous monitoring of the quality of medicines in order to ensure quality is maintained and substandard products removed from the pharmaceutical supply chain.
Collapse
Affiliation(s)
- Elimas Jere
- Zambia Medicines Regulatory Authority, Lusaka, Zambia
| | | | - Moses Mukosha
- School of Health Sciences, University of Zambia, Lusaka, Zambia
| | - Steward Mudenda
- School of Health Sciences, University of Zambia, Lusaka, Zambia
| | | | | |
Collapse
|
19
|
Alemkere G, Tegegne GT, Molla GA, Belayneh A, Muzeyin H, Shewarega W, Degefaw Y, Melkie A, Getahun W, Tadeg H, Alemayehu A, Girma E, Amogne W. Etiquette of the antibiotic decision-making process for surgical prophylaxis in Ethiopia: a triangulated ethnographic study. Front Public Health 2023; 11:1251692. [PMID: 38192548 PMCID: PMC10773818 DOI: 10.3389/fpubh.2023.1251692] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2023] [Accepted: 11/22/2023] [Indexed: 01/10/2024] Open
Abstract
Background Prophylactic antibiotics reduce surgery-associated infections and healthcare costs. While quantitative methods have been widely used to evaluate antibiotic use practices in surgical wards, they fall short of fully capturing the intricacies of antibiotic decision-making in these settings. Qualitative methods can bridge this gap by delving into the often-overlooked healthcare customs that shape antibiotic prescribing practices. Aim This study aimed to explore the etiquette of the antibiotic decision-making process of surgical prophylaxis antibiotic use at Tikur Anbessa Specialized Hospital (TASH). Methods The observational study was carried out at TASH, a teaching and referral hospital in Addis Ababa, Ethiopia, from 26 August 2021 to 1 January 2022. Overall, 21 business ward rounds, 30 medical record reviews, and 11 face-to-face interviews were performed sequentially to triangulate and cross-validate the qualitative observation. The data were collected until saturation. The data were cleaned, coded, summarized, and analyzed using the thematic analysis approach. Result Surgical antibiotic prophylaxis (SAP) discussions were infrequent during surgical ward rounds in TASH, leading to practices that deviated from established recommendations. Clear documentation differentiating SAP from other antibiotic uses was also lacking, which contributed to unjustified extended SAP use in the postoperative period. Missed SAP documentation was common for emergency surgeries, as well as initial dose timing and pre-operative metronidazole administration. Importantly, there was no standardized facility guideline or clinical protocol for SAP use. Furthermore, SAP prescriptions were often signed by junior residents and medical interns, and administration was typically handled by anesthesiologists/anesthetists at the operating theater and by nurses in the wards. This suggests a delegation of SAP decision-making from surgeons to senior residents, then to junior residents, and finally to medical interns. Moreover, there was no adequate representation from pharmacy, nursing, and other staff during ward rounds. Conclusion Deeply ingrained customs hinder evidence-based SAP decisions, leading to suboptimal practices and increased surgical site infection risks. Engaging SAP care services and implementing antimicrobial stewardship practices could optimize SAP usage and mitigate SSI risks.
Collapse
Affiliation(s)
- Getachew Alemkere
- Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
- USAID Medicines, Technologies, and Pharmaceutical Services Program, Management Sciences for Health, Addis Ababa, Ethiopia
| | - Gobezie T. Tegegne
- Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
| | - Getnet Abebe Molla
- Department of Surgery, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
| | - Alemu Belayneh
- Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
| | - Hanan Muzeyin
- Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
| | - Wendwosen Shewarega
- Antimicrobial Resistance Prevention and Control Case Team, Pharmaceuticals and Medical Devices Lead Executive Office, Ministry of Health, Addis Ababa, Ethiopia
| | - Yidnekachew Degefaw
- Antimicrobial Resistance Prevention and Control Case Team, Pharmaceuticals and Medical Devices Lead Executive Office, Ministry of Health, Addis Ababa, Ethiopia
| | - Addisu Melkie
- Division of Nephrology, Department of Internal Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
| | - Workineh Getahun
- USAID Medicines, Technologies, and Pharmaceutical Services Program, Management Sciences for Health, Addis Ababa, Ethiopia
| | - Hailu Tadeg
- USAID Medicines, Technologies, and Pharmaceutical Services Program, Management Sciences for Health, Addis Ababa, Ethiopia
| | - Abebe Alemayehu
- Department of Surgery, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
| | - Eshetu Girma
- Department of Preventive Medicine, School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
| | - Wondwossen Amogne
- Department of Internal Medicine, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
| |
Collapse
|
20
|
Nale JY, Chan B, Nnadi NE, Cheng JKJ, Matts S, Nezam-Abadi N, Turkington CJR, Charreton LM, Bola H, Nazir R, Hoza AS, Wamala SP, Ibanda I, Maina AN, Apopo AA, Msoffe VT, Moremi N, Moore GW, Asiimwe I, Namatovu A, Mutumba P, Kamya D, Nabunje R, Nakabugo I, Kazwala RR, Kangethe E, Negash AA, Watelo AK, Bukamba N, Muhindo G, Lubowa NM, Jillani N, Nyachieo A, Nasinyama G, Nakavuma J, Millard A, Nagel TE, Clokie MRJ. Novel Escherichia coli-Infecting Bacteriophages Isolated from Uganda That Target Human Clinical Isolates. PHAGE (NEW ROCHELLE, N.Y.) 2023; 4:141-149. [PMID: 37841386 PMCID: PMC10574529 DOI: 10.1089/phage.2023.0012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2023]
Abstract
Background The antimicrobial resistance catastrophe is a growing global health threat and predicted to be worse in developing countries. Phages for Global Health (PGH) is training scientists in these regions to isolate relevant therapeutic phages for pathogenic bacteria within their locality, and thus contributing to making phage technology universally available. Materials and Methods During the inaugural PGH workshop in East Africa, samples from Ugandan municipal sewage facilities were collected and two novel Escherichia coli lytic phages were isolated and characterized. Results The phages, UP19 (capsid diameter ∼100 nm, contractile tail ∼120/20 nm) and UP30 (capsid diameter ∼70 nm, noncontractile tail of ∼170/20 nm), lysed ∼82% and ∼36% of the 11 clinical isolates examined, respectively. The genomes of UP19 (171.402 kb, 282 CDS) and UP30 (49.834 kb, 75 CDS) closely match the genera Dhakavirus and Tunavirus, respectively. Conclusion The phages isolated have therapeutic potential for further development against E. coli infections.
Collapse
Affiliation(s)
- Janet Yakubu Nale
- Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom
- Centre for Epidemiology and Planetary Health, School of Veterinary Medicine, Scotland's Rural College, Inverness, Scotland, United Kingdom
| | - Benjamin Chan
- Department of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut, USA
| | - Nnaemeka Emmanuel Nnadi
- Department of Microbiology, Faculty of Natural and Applied Sciences, Plateau State University, Bokkos, Nigeria
| | - Jeffrey Kwok Jone Cheng
- Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom
- School of Life Sciences, The University of Warwick, Coventry, United Kingdom
| | - Susan Matts
- Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom
| | - Neda Nezam-Abadi
- Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom
- APC Microbiome Ireland and School of Microbiology, University College Cork, Cork, Ireland
| | - Christopher Jason Richard Turkington
- Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom
- APC Microbiome Ireland and School of Microbiology, University College Cork, Cork, Ireland
| | - Lucie Manon Charreton
- Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom
- Sciences et Humanités, École Supérieur de Biologie, Biochimie, Lyon, France
| | - Harroop Bola
- Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom
- Imperial College School of Medicine, London, United Kingdom
| | - Ramez Nazir
- Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom
- Yale-Waterbury Internal Medicine, Waterbury, Connecticut, USA
| | - Abubakar Shaaban Hoza
- Department of Veterinary Microbiology, Parasitology & Biotechnology, College of Veterinary Medicine & Biomedical Sciences, Sokoine University of Agriculture, Morogoro, Tanzania
| | - Samuel Posian Wamala
- Department of Biotechnical and Diagnostic Science, College of Veterinary Medicine, Makerere University, Kampala, Uganda
| | - Ivan Ibanda
- Department of Pharmacology and Therapeutics, School of Medicine and Surgery, King Ceasor University, Kampala, Uganda
| | - Alice Nyambura Maina
- Department of Biology, University of Nairobi, Nairobi, Kenya
- Department of Food Science and Technology, Technical University of Kenya, Nairobi, Kenya
| | | | - Venance Theophil Msoffe
- Department of Biological Sciences, Mkwawa University College of Education, The Constituent College of University of Dar es Salaam, Iringa, Tanzania
| | - Nyambura Moremi
- Department of Research, National Public Health Laboratory, Dar es Salaam, Tanzania
| | - Grace Wanjiru Moore
- Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya
| | - Ismail Asiimwe
- Department of Biomolecular Resources and Biolab Sciences, School of Biosecurity, Biotechnical and Laboratory Sciences, College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala, Uganda
| | - Alice Namatovu
- Department of Biomolecular Resources and Biolab Sciences, School of Biosecurity, Biotechnical and Laboratory Sciences, College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala, Uganda
| | - Paul Mutumba
- Department of Biomolecular Resources and Biolab Sciences, School of Biosecurity, Biotechnical and Laboratory Sciences, College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala, Uganda
| | - Deus Kamya
- Department of Biomolecular Resources and Biolab Sciences, School of Biosecurity, Biotechnical and Laboratory Sciences, College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala, Uganda
| | - Ritah Nabunje
- Department of Biomolecular Resources and Biolab Sciences, School of Biosecurity, Biotechnical and Laboratory Sciences, College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala, Uganda
| | - Immaculate Nakabugo
- Department of Biomolecular Resources and Biolab Sciences, School of Biosecurity, Biotechnical and Laboratory Sciences, College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala, Uganda
| | - Rudovick Ruben Kazwala
- Department of Veterinary Medicine & Public Health, College of Veterinary Medicine & Biomedical Sciences, Sokoine University of Agriculture, Morogoro, Tanzania
| | - Erastus Kangethe
- Department of Public Health, Pharmacology and Toxicology, University of Nairobi, Nairobi, Kenya
| | - Abel Abera Negash
- Armauer Hansen Research Institute, Addis Ababa, Ethiopia
- Department of Microbiology, Immunology and Parasitology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia
| | | | - Nelson Bukamba
- Mountain Gorilla Veterinary Project Inc, Department of Wildlife and Aquatic Resources Management, College of Veterinary Medicine, Makerere University Kampala, Uganda
| | | | - Nathan Musisi Lubowa
- Department of Biotechnical and Diagnostic Science, College of Veterinary Medicine, Makerere University, Kampala, Uganda
| | - Ngalla Jillani
- Phage Biology Laboratory, Institute of Primate Research, Karen Nairobi, Kenya
| | - Atunga Nyachieo
- Phage Biology Laboratory, Institute of Primate Research, Karen Nairobi, Kenya
| | - George Nasinyama
- Department of Public Health Kampala International University, Kampala, Uganda
- School of Sciences, Health Sciences, Technology, and Engineering, Unicaf University, Kampala, Uganda
| | - Jesca Nakavuma
- Department of Biomolecular Resources and Biolab Sciences, School of Biosecurity, Biotechnical and Laboratory Sciences, College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala, Uganda
| | - Andrew Millard
- Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom
| | | | | |
Collapse
|
21
|
Aruhomukama D, Nakabuye H. Investigating the evolution and predicting the future outlook of antimicrobial resistance in sub-saharan Africa using phenotypic data for Klebsiella pneumoniae: a 12-year analysis. BMC Microbiol 2023; 23:214. [PMID: 37553587 PMCID: PMC10408162 DOI: 10.1186/s12866-023-02966-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2023] [Accepted: 08/01/2023] [Indexed: 08/10/2023] Open
Abstract
BACKGROUND Antimicrobial resistance (AMR) is a major public health challenge, particularly in sub-Saharan Africa (SSA). This study aimed to investigate the evolution and predict the future outlook of AMR in SSA over a 12-year period. By analysing the trends and patterns of AMR, the study sought to enhance our understanding of this pressing issue in the region and provide valuable insights for effective interventions and control measures to mitigate the impact of AMR on public health in SSA. RESULTS The study found that general medicine patients had the highest proportion of samples with AMR. Different types of samples showed varying levels of AMR. Across the studied locations, the highest resistance was consistently observed against ceftaroline (ranging from 68 to 84%), while the lowest resistance was consistently observed against ceftazidime avibactam, imipenem, meropenem, and meropenem vaborbactam (ranging from 92 to 93%). Notably, the predictive analysis showed a significant increasing trend in resistance to amoxicillin-clavulanate, cefepime, ceftazidime, ceftaroline, imipenem, meropenem, piperacillin-tazobactam, and aztreonam over time. CONCLUSIONS These findings suggest the need for coordinated efforts and interventions to control and prevent the spread of AMR in SSA. Targeted surveillance based on local resistance patterns, sample types, and patient populations is crucial for effective monitoring and control of AMR. The study also highlights the urgent need for action, including judicious use of antibiotics and the development of alternative treatment options to combat the growing problem of AMR in SSA.
Collapse
Affiliation(s)
- Dickson Aruhomukama
- Department of Medical Microbiology, College of Health Sciences, Makerere University, Kampala, Uganda.
| | - Hellen Nakabuye
- Department of Medical Microbiology, College of Health Sciences, Makerere University, Kampala, Uganda
| |
Collapse
|
22
|
Akenten CW, Khan NA, Mbwana J, Krumkamp R, Fosu D, Paintsil EK, Boahen KG, Osei-Mensa J, Maiga-Ascofare O, May J, Obiri-Danso K, Phillips RO, Ofori LA, Dekker D. Carriage of ESBL-producing Klebsiella pneumoniae and Escherichia coli among children in rural Ghana: a cross-sectional study. Antimicrob Resist Infect Control 2023; 12:60. [PMID: 37400910 DOI: 10.1186/s13756-023-01263-7] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2023] [Accepted: 06/04/2023] [Indexed: 07/05/2023] Open
Abstract
BACKGROUND Extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae (ESBL-KP) and Escherichia coli (ESBL-EC) present a high burden in both communities and healthcare sectors, leading to difficult-to-treat infections. Data on intestinal carriage of ESBL-KP and ESBL-EC in children is scarce, especially in sub-Saharan African countries. We provide data on faecal carriage, phenotypic resistance patterns, and gene variation of ESBL-EC and ESBL-KP among children in the Agogo region of Ghana. METHODS From July to December 2019, fresh stool samples were collected within 24 h from children < 5 years with and without diarrhoea attending the study hospital. The samples were screened for ESBL-EC and ESBL-KP on ESBL agar and confirmed using double-disk synergy testing. Bacterial identification and an antibiotic susceptibility profile were performed using the Vitek 2 compact system (bioMérieux, Inc.). ESBL genes, blaSHV, blaCTX-M, and blaTEM were identified by PCR and further sequencing. RESULTS Of the 435 children recruited, stool carriage of ESBL-EC and ESBL-KP was 40.9% (n/N = 178/435) with no significant difference in prevalence between children with diarrhoea and non-diarrhoea. No association between ESBL carriage and the age of the children was found. All isolates were resistant to ampicillin and susceptible to meropenem and imipenem. Both ESBL-EC and ESBL-KP isolates showed over 70% resistance to tetracycline and sulfamethoxazole-trimethoprim. Multidrug resistance was observed in over 70% in both ESBL-EC and ESBL-KP isolates. The blaCTX-M-15 was the most prevalent ESBL gene detected. blaCTX-M-27, blaCTX-M-14, and blaCTX-M-14b were found in non-diarrhoea stools of children, whereas blaCTX-M-28 was found in both the diarrhoea and non-diarrhoea patient groups. CONCLUSIONS The carriage of ESBL-EC and ESBL-KP among children with and without diarrhoea in the Agogo community with a high prevalence of blaCTX-M-15 is noteworthy, highlighting the importance of both the population as a possible reservoir. This study reports for the first time the ESBL gene blaCTX-M-28 among the studied populations in Ghana.
Collapse
Affiliation(s)
| | - Neyaz Ahmed Khan
- One Health Bacteriology Group, Bernhard Nocht Institute for Tropical Medicine, Hamburg, 20359, Germany.
| | - Joyce Mbwana
- National Institute for Medical Research, Tanga, Tanzania
| | - Ralf Krumkamp
- Infectious Disease Epidemiology Department, Bernhard Nocht Institute for Tropical Medicine, Hamburg, 20359, Germany
- German Centre for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems, Germany
| | - Dennis Fosu
- Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana
| | | | | | - James Osei-Mensa
- Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana
| | - Oumou Maiga-Ascofare
- Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana
- Infectious Disease Epidemiology Department, Bernhard Nocht Institute for Tropical Medicine, Hamburg, 20359, Germany
- German Centre for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems, Germany
| | - Jürgen May
- Infectious Disease Epidemiology Department, Bernhard Nocht Institute for Tropical Medicine, Hamburg, 20359, Germany
- German Centre for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems, Germany
- University Medical Centre Hamburg-Eppendorf (UKE), Tropical Medicine, Hamburg, Germany
| | | | | | | | - Denise Dekker
- One Health Bacteriology Group, Bernhard Nocht Institute for Tropical Medicine, Hamburg, 20359, Germany
| |
Collapse
|